Presentations Will Also Emphasize Clinician
Education and Expanding Scope of Practice for Vascular Access
Specialists
Teleflex Incorporated (NYSE:TFX), a leading provider of medical
technologies for critical care and surgery, will showcase its new
Arrow Endurance™ Extended Dwell Peripheral Catheter System at the
29th Annual Scientific Meeting of the Association for Vascular
Access, in Dallas, Texas, to be held Sept. 26-29, 2015.
The Arrow Endurance™ System will be discussed at a Platinum
Showcase titled “The New Age of Midlines and the Arrow Endurance™
Extended Dwell Peripheral Catheter System”, presented by Nancy
Moureau, BSN, RN, CRNI, CPUI, VA-BC™. The event will be held
Monday, Sept. 28 from 4:50 p.m. to 5:50 p.m. in room Grapevine
A.
Teleflex will have the extended dwell catheter system exhibited
at Booth 501 in the Exhibit Hall so attendees can have hands-on
experience with the device.
The Arrow Endurance™ System is cleared by the FDA to dwell up to
29 days. The Arrow Endurance™ System enables hospitals to avoid
using multiple peripheral IVs to achieve longer dwell times while
also avoiding the extra clinical risks and expenses associated with
a peripherally inserted central catheter (PICC). The Arrow
Endurance™ Catheter is intended for short-term use (up to 29 days)
to permit delivery of infusion therapies, pressure monitoring, high
pressure injection (325 psi max.), and withdrawal of blood. To
learn more about the Arrow Endurance™ Extended Dwell Peripheral
Catheter System, please visit arrowendurance.com.
Teleflex's activities at this year’s AVA will focus on clinician
education, enabling non-physician inserters to insert CVCs and
arterial lines, and supporting clinicians in always selecting the
right line for their patients.
“There are many vital choices that must be made so a patient
gets the safest, most effective IV therapy possible. Our philosophy
of “Right Line. Right Patient. Right Time.™” helps us deliver
products that align with safe patient care,” said Jay White,
President of the Vascular Access Division of Teleflex. “The Arrow
Endurance™ Catheter continues to build upon this philosophy. We
look forward to launching this product at this year’s AVA meeting
as well as providing an additional line-up of clinical education
opportunities.”
A breakfast symposium titled “Growing the Vascular Access
Specialty: Expanding Your Practice to CVCs, Arterial Lines, and
Beyond” will be held on Sunday, Sept. 27 from 7:00 a.m. to 8:45
a.m. in room Texas C. The presenters are clinical nurse educator
Connie Girgenti, RN, VA-BC™; Keegan Mahoney, BS, RRT, vascular
access specialist in Mesa, Arizona; and Amy Bardin-Spencer.
Girgenti is the co-author of the recently published article, “A
Vascular Access Team’s Journey to Central Venous Catheter and
Arterial Line Placement”, which appeared in the June 2015 issue of
the Journal of the Association for Vascular Access.
Teleflex thought leaders are involved in several clinician
education offerings at the conference. Among them is a dinner
symposium, “Chlorhexidine: The Agent, the Legacy, the Novelty” with
presenters Kamna Giare-Patel, MS, RN and Amy Bardin-Spencer, MS,
RRT, VA-BC™. Patel is Director, Research and Development at
Teleflex, and she has done extensive work in developing
chlorhexidine protected catheters. Bardin-Spencer is a Senior
Clinical Marketing Specialist for the company. The symposium will
be held Sunday, Sept. 27 from 6:15 p.m. to 8:15 p.m. in room Texas
C.
Teleflex will also have clinical education activities at its
booth, where phantoms and models will be used to demonstrate the
full range of the company’s vascular access devices. The company is
also offering its popular Vascular Access Procedural Cadaver Lab at
the meeting site.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
VA-BC is a trademark of The Vascular Access Certification
Corporation.Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson
RCI, LMA, Pilling, Rusch, Weck, and Arrow Endurance are trademarks
or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries.© 2015 Teleflex
Incorporated. All rights reserved. MC-001436
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150923005213/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024